Dutch Techcentre for Life Sciences
|
|
|
- Evan James
- 9 years ago
- Views:
Transcription
1 Dutch Techcentre for Life Sciences next generation life science technology research infrastructure : cross-sector technology initiative Nieuwegein, 19 december 2011 Ruben Kok, Barend Mons, Jaap Heringa, Marcel Reinders; bioinformatics, NBIC Roel van Driel; systems biology, NCSB Thomas Hankemeijer, Merlijn van Rijswijk; metabolomics, NMC Albert Heck, Werner Most; proteomics, NPC Edwin Cuppen, Terry Vrijenhoek; genome diagnostics, CGD Dorus Gadella, Judith Klumperman, light microscopy, NL BioImaging AM
2 established as an integrated and cross-sector technology research infrastructure From fragmented technology activities towards an integrated cross-sector infrastructure
3 VISION Dutch Techcentre for Life sciences: next generation LS technology research infrastructure Framework of key tech expert centres genomics (NGS) proteomics metabolomics bioimaging bioinformatics, systems biology & e-science
4 VISION offers a big technology research infrastructure to enable LS-based topsectors Quality, tuning and access cutting-edge technology research cross-technology data integration expertise & infrastructures support & training single framework cross-sector tuning international link and impact public-private partnerships
5 VISION Technology research infrastructure to enable LS-based topsectors Access to infrastructures & expertise research support hotels & services in house & global technologies experimental technologies & data aspects education of specialists, training of users access to industry; SME-programme tech transfer to commercial providers part of international facilities (e.g. ESFRI)
6 and DBH as linking pin to European infrastructures ESFRI ELIXIR
7 DISC ELIXIR: broad founding alliance LS data infrastructure Compute and storage infrastructure Tools infrastructure Expertise infrastructure Training infrastructure CGD
8 Essential for LSH and other Topsectors Topsectoren LS&H Agrofood Tuinbouw en uitgangsmaterialen Chemie Hightech materials LS&H roadmaps Molecular diagnostics. Imaging and Image guided therapy Regenerative Medicine Pharmacotherapy One Health Specialized Nutrition, Health and Disease
9 industry proposition Technology users Existing industry collaboration over 70 companies across all topsectors various ways of involvement Industry Platform joint research projects research services (short-term) training & kenniswerken from 2012 new collaboration strategies and targets will be defined in cooperation with industry Service Providers Technology developers
10 VISION funding Research NWO/ZonMW/STW FP8, IMI, FET flagship projects academia: van basic funding industry in cash/kind Hotels & services facility grants (roadmap?), NWO-groot, academia: via basic funding >50%: backpack budget in user projects Education & training academia: via basis funding miscellaneous grants
11 VISION annual funding ambitions Total NL 35% EU 15% Acad. 35% 40 % 24M Ind. 15% 40% 24M % 3 M % 6 M % 3 M
12 Dutch Techcentre for Life Sciences next generation life science technology research infrastructure
13 Companies already involved in centres Abbott Agilent Technologies Arcarios Artemis Pharmaceuticals Arthrogen BaseClear BIOBASE GmbH Bioceros Bruker Carls Zeiss Cellzome AG CiberNed CLC bio Convey Computers Crosslinks Dalicon BV Danone Darwin Digits DSM decode Genetics Eli Lilly Epigeomics AG FEI Electron Optics Friensland Campina Galapagos GeneAlice Genome Diagnostics Genmab Harbour Antibodies Heineken Hybrigenics IBM Jansen Pharmaceutica Johnson and Johnson Keygene Merus B.V. Monsanto Nestlé NIZO Novartis Open Analytics Organon/Merck PamGene B.V. Perch Pfizer Philips Pluriomics Profibrix Purac Roche RijkZwaan Breeding Source BioScience Spark-Holland S&T Bioinformatics Thermo Scientific UbiQ Unilever Veridex LLC Waters XomicX
DTL AS CROSS-SECTOR TECHNOLOGY PLATFORM
DTL AS CROSS-SECTOR TECHNOLOGY PLATFORM Enabling next generation life science research workshop Utrecht, October 23, 2013 AN INTEGRATED APPROACH TO BIG SCIENCE & DATA genomics/ngs proteomics metabolomics
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences WP11 Data Storage and Analysis Task 11.1 Coordination Deliverable 11.2 Community Needs of
Effects of NGI investments
June 26, 2012 Effects of NGI investments Study commissioned by the Netherlands Genomics Initiative www.technopolis-group.com Effects of NGI investments Study commissioned by the Netherlands Genomics Initiative
Conditions for Accreditation as (Basic) Pharmacologist
NEDERLANDSE VERENIGING VOOR FARMACOLOGIE DUTCH PHARMACOLOGICAL SOCIETY Conditions for Accreditation as (Basic) Pharmacologist 1. Introduction The Dutch Pharmacological Society (DPS) is the organization
EBiSC the first European bank for induced pluripotent stem cells
Press Release EBiSC the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Molecular Biology Laboratory Case Example
European Molecular Biology Laboratory Case Example Dr. Silke Schumacher Director International Relations EMBL Member States Austria 1974 Denmark 1974 France 1974 Germany 1974 Israel 1974 Italy 1974 Netherlands
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
6 ELIXIR Domain Specific Services
6 ELIXIR Domain Specific Services Work stream leads: Alfonso Valencia (ES), Inge Jonassen (NO), Jose Leal (PT) Work stream members: Nils-Peder Willassen (NO), Finn Drablos (NO), Mark Viant (UK), Ferran
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences WP11 Data Storage and Analysis Task 11.1 Coordination Deliverable 11.3 Selected Standards
Master of Science in BIOINFORMATICS. > information. > insight. > innovation
Master of Science in BIOINFORMATICS > information > insight > innovation The Program Master of Science in Bioinformatics The College of Science at Northeastern University is committed to delivering cutting-edge
Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research
Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from
Implementation Regulation for the MSc Programme Nanobiology
Implementation Regulation for the MSc Programme Nanobiology Part of the Course and Exam Regulation of the Master Programme As referred to in Section 2 of the Course and Exam Regulation. Faculty of Medicine
Laboratory medicine as one of the pharmacists competencies
2014 EAFP Annual Conference Laboratory medicine as one of the pharmacists competencies Borut Božič Examinations of the body fluids in order to recognize the state of health of the individuals Greco-Roman
TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298
DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES MAY 2014. May 2014 ABA 298 1 Technologies, Products & Services
Public-private Partnerships in Chemistry: Funding Opportunities in the NWO Fund New Chemical Innovations
Public-private Partnerships in Chemistry: Funding Opportunities in the NWO Fund New Chemical Innovations CW Study Group Meetings 2013-2014 FM Meeting 11 February 2014 Maarten de Zwart and Mark Kas Nederlandse
Join our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
ITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
Las Tecnologías de la Información y de la Comunicación en el HORIZONTE 2020
Las Tecnologías de la Información y de la Comunicación en el HORIZONTE 2020 A Coruña, 2 de Diciembre de 2013 Luis Rodríguez-Roselló ex-jefe de Unidad Network Technologies European Commission - DG CONNECT
Amsterdam RAI. Shaping the future of healthcare through prevention, diagnosis, cure and care. www.innovationforhealth.eu
Amsterdam RAI Shaping the future of healthcare through prevention, diagnosis, cure and care The premier event for innovations in healthcare and prevention Innovation for Health features thought-provoking
Nanomedicine in Horizon 2020
Nanomedicine in Horizon 2020 Heico FRIMA Programme Officer European Commission Directorate-General for Research & Directorate D: Key Enabling Technologies [email protected] ETPN Annual Event 2014
Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform
PRESS RELEASE Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform Pivot Park Screening Centre in Oss will play an important role in a new pan-european drug
Santaravalley: Integrating scientific research, high-tech business and academia Prof. Vladas Algirdas Bumelis President of Santara valley Association Vilnius, Lithuania 2013July 18 th Santara Valley Association
Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se
Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in
Faculty of Applied Sciences. Bachelor s degree programme. Nanobiology. Integrating Physics with Biomedicine
Faculty of Applied Sciences Bachelor s degree programme Nanobiology Integrating Physics with Biomedicine We have just begun to explore life on this level Nanobiology uses the language of maths in the context
The National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
Master of Philosophy (MPhil) and Doctor of Philosophy (PhD) Programs in Life Science
CURRICULUM FOR RESEARCH POSTGRADUATE PROGRAMS Master of Philosophy (MPhil) and Doctor of Philosophy (PhD) Programs in Life Science Curriculum for Master of Philosophy (MPhil) Program in Life Science The
Presentations session national funding HTSM RVO
Presentations session national funding EZ HTSM RVO Innovation instruments Session National funding and TKI HTSM UT Grants Week 21 October 2014 Marjolijn van Valkenhoef Ministry of Economic Affairs Department
Biochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!!
Biochemistry Major Talk 2014-15 August 14, 2015 Department of Biochemistry The University of Hong Kong Welcome!!!!!!!!!!!!!! Introduction to Biochemistry A four-minute video: http://www.youtube.com/watch?v=tpbamzq_pue&l
Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure
Policy Issues in the Economics and Financing of Medical Technology in the Asia-Pacific Region Dr KAI HONG PHUA Joint Professor Yong Loo Lin School of Medicine and Lee Kuan Yew School of Public Policy National
Personalized medicine in China s healthcare system
Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL
Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form
C H I Cambridge Healthtech Institute s Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form Over 800,000 names segmented by scientific interest Featuring U.S and International
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
1. What are the key strengths and weaknesses of the UK s innovation system in relation to business-university collaboration?
ABPI S RESPONSE TO THE BUSINESS, INNOVATION AND SKILLS SELECT COMMITTEE INQUIRY INTO THE STRENGTHS AND WEAKNESSES OF BUSINESS-UNIVERSITY COLLABORATION IN THE UK AND THE UK S PERFORMANCE AGAINST INTERNATIONAL
THE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
DNA Sequencing and PCR Markets
Brochure More information from http://www.researchandmarkets.com/reports/41864/ DNA Sequencing and PCR Markets Description: DNA sequencing and polymerase chain reaction (PCR) are two major technology platforms
MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015
19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All
Components of Geonomics and Bio-Informatics
Components of Geonomics and Bio-Informatics Shankar Srinivasan, PhD Department of Health Informatics University of Medicine and Dentistry of New Jersey Newark, New Jersey World Health Organization (WHO)
Technology funding opportunities at the National Cancer Institute
Technology funding opportunities at the National Cancer Institute Through the Cancer Diagnosis Program http://cancerdiagnosis.nci.nih.gov/index.html Avraham Rasooly Ph.D. National Cancer Institute, Cancer
FACULTY OF MEDICAL SCIENCE
Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research
INVESTMENT IN DISRUPTIVE EXPONENTIAL TECHNOLOGIES
INVESTMENT IN DISRUPTIVE EXPONENTIAL TECHNOLOGIES Deep Knowledge Ventures Deep Knowledge Ventures is a Hong Kong investment fund focusing on biotechnology, regenerative medicine, drug discovery, Artificial
BIOMEDICAL ENGINEERING UNDERGRADUATE CURRICULUM
BIOMEDICAL ENGINEERING UNDERGRADUATE CURRICULUM 2014-2015 (as of 4/26/2013) This program is accredited by the Engineering Accreditation Commission of ABET, http://www.abet.org. Undergraduate Program Mission
Joy Doran-Peterson, Director MBB Program www.biomanufacturing.uga.edu. A degree program of the UGA Biomedical and Health Sciences Institute
Training the Next Generation of Fermentation Scientists at UGA via the Professional Science Master of Biomanufacturing and Bioprocessing Or Using Your Resources to Answer a Wake-up Call Joy Doran-Peterson,
Preparing the scenario for the use of patient s genome sequences in clinic. Joaquín Dopazo
Preparing the scenario for the use of patient s genome sequences in clinic Joaquín Dopazo Computational Medicine Institute, Centro de Investigación Príncipe Felipe (CIPF), Functional Genomics Node, (INB),
Dr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
Future and Emerging Technologies (FET) in H2020. Ales Fiala Future and Emerging Technologies DG CONNECT European Commission
Future and Emerging Technologies (FET) in H2020 51214 Ales Fiala Future and Emerging Technologies DG CONNECT European Commission H2020, three pillars Societal challenges Excellent science FET Industrial
2019 Healthcare That Works for All
2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To
A career on the science park
A career on the science park Onno van de Stolpe December 2014 Copyright 2014 Galapagos NV 1987 MOGEN Agricultural biotech pioneer Design of transgenic plants with improved traits Close link with Prof Schilperoort
Quo vadis Pharmaceutical Industry? New strategies to overcome the innovation gap
Quo vadis Pharmaceutical Industry? New strategies to overcome the innovation gap Jochen Maas Stuttgart, May 2014 Quo vadis Pharmaceutical Industry? R&D in the pharmaceutical industry - still a valid model?
Department of Biomedical Engineering Curriculum Summary for MS Degree
Department of Biomedical Engineering Curriculum Summary for MS Degree Biology/Medicine BMME 570: Genes to Tissue (Fall 2010)* 7 credits (Both Required) BMME 790: Systems Physiology for Biomedical Engineers
Kazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology. Master s program.
Kazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology Master s program Bioinformatics I. THEORETICAL BASIS The development of effective technologies of theoretical
Future Smart Cities. Dr. James Canton CEO & Chairman GlobalFuturist.com
Future Smart Cities Dr. James Canton CEO & Chairman GlobalFuturist.com Are you Future-Ready What is your Vision? Institute for Global Futures Think Tank: Forecast Future Trends, Global Advisory Keynotes,
Health Informatics Research and Development in Europe
Workshop on Health Informatics Research and Development, London, 18 July 2002 Health Informatics Research and Development in Europe Sofie Nørager European Commission Information Society Technologies Program
Master of Science in Vision Science and Investigative Ophthalmology MVSIO
Master of Science in Vision Science and Investigative Ophthalmology MVSIO Global Leadership in Eye Care, Vision Research and Ophthalmology Education Bascom Palmer Eye Institute is pleased to introduce
The 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
IMMUNOCHEMICALS - A Global Strategic Business Report
/wepdwukltuyot IMMUNOCHEMICALS - A Global Strategic Business Report 联 系 购 买 电 话 :010-82863480 公 司 名 称 : 佐 思 信 息 公 司 地 址 : 北 京 市 海 淀 区 苏 州 街 18 号 院 长 远 天 地 大 厦 A2 座 1008-1 室 (100080) 出 版 日 期 :April 2011
Toward Acceleration of Open Innovation
Toward Acceleration of Open Innovation ーThe Role of Industrial-Academic- Government-Collaborationー Masafumi Nogimori Representative Director and Chairman Astellas Pharm Inc. International Symposium New
Master of Science in Biophysics, Biochemistry and Biotechnology
Master of Science in Biophysics, Biochemistry and Biotechnology Tracks: Biophysics Biochemistry and Biotechnology Faculty of Science Faculty of Medicine KU Leuven. Inspiring the outstanding. Discover KU
Bio-economy in the Netherlands
Bio-economy in the Netherlands Roel Bol Director Biobased Economy Ministry of Economic Affairs, Agriculture and Innovation The Netherlands 28th November 2012 Economic Policy Perspective - International
FACULTY OF MEDICAL SCIENCE
Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern
Molecular Biotechnology Master s Degree Program
> APPLIED LIFE SCIENCES Master s Degree Program: > FULL TIME Molecular Biotechnology Master s Degree Program www.fh-campuswien.ac.at My Occupational Future. Your Career Opportunities Biotechnology is one
2015 Employment Report
Corporate Connections. Career Results. 2015 Employment Report www.smeal.psu.edu/mba Corporate Connections. Career Results. 1 Table of Contents Class of 2015 Full-Time Employment Class of 2016 Internship
BIOSCIENCES COURSE TITLE AWARD
COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,
EMBL Identity & Access Management
EMBL Identity & Access Management Rupert Lück EMBL Heidelberg e IRG Workshop Zürich Apr 24th 2008 Outline EMBL Overview Identity & Access Management for EMBL IT Requirements & Strategy Project Goal and
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
It s our people that make the difference
It s our people that make the difference 2 CONTENTS Welcome page 2 About KeyGene page 3 Personal & Professional page 4 KeyGene offers page 11 KeyGene Learning Academy page 13 Keep in Touch page 14 3 WELCOME
The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art
GRADUATE PROGRAMS The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art research centers and experiential
Human Health Sciences
Human Health Sciences WITH PLYMOUTH UNIVERSITY DISCOVER MORE If you would like to visit Plymouth and meet our staff, then why not come along to one of our open days. Human Health Sciences WITH PLYMOUTH
Master BioMedical Sciences (BMS) Track Cell Biology and Advanced Microscopy
Master BioMedical Sciences (BMS) Track Cell Biology and Advanced Microscopy The five tracks offered in the Medical Biology cluster are: Biochemistry and Metabolic Diseases Cell Biology and Advanced Microscopy
Big Data An Opportunity or a Distraction? Signal or Noise?
Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28
Building innovative drug discovery alliances. Introducing JChem for SharePoint at Evotec
Building innovative drug discovery alliances Introducing JChem for SharePoint at Evotec Evotec AG, Introducing JChem for SharePoint at Evotec, 22 nd May 2012 Agenda About Evotec About SharePoint SharePoint